Efficacy and safety of Aflibercept for the treatment of inflammatory choroidal neovascularization: The ALINEA study.
Saved in:
| Title: | Efficacy and safety of Aflibercept for the treatment of inflammatory choroidal neovascularization: The ALINEA study. |
|---|---|
| Authors: | Kodjikian L; Hospices Civils de Lyon, Service d'Ophtalmologie, Centre Hospitalier Universitaire de la Croix-Rousse, Lyon, France.; Université Lyon 1, Lyon, France.; UMR5510 MATEIS, CNRS, INSA Lyon, Université Lyon 1, Villeurbanne, France., Abukhashabah A; Hospices Civils de Lyon, Service d'Ophtalmologie, Centre Hospitalier Universitaire de la Croix-Rousse, Lyon, France.; Ophthalmology Department, King Abdulaziz University, Rabigh, Saudi Arabia., Fardeau C; Ophthalmology Department, Reference Center for Rare Diseases, La Pitié-Salpêtriètre Hospital, Paris-Sorbonne University, Paris, France., Tadayoni R; Université de Paris, Service d'Ophtalmologie, AP-HP, Hôpital Lariboisière, Paris, France.; Service d'Ophtalmologie, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France., Brézin A; Hôpital Cochin, Service d'Ophtalmologie, Université de Paris, Paris, France., Dumas S; Centre Nordretine, Lille, France., Weber M; Hôpital Universitaire Centre Nantes, Nantes, France., Bernard L; Université Lyon 1, Lyon, France.; Pôle de Santé Publique, Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Lyon, France.; CNRS, UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, Villeurbane, France., Loria O; Hospices Civils de Lyon, Service d'Ophtalmologie, Centre Hospitalier Universitaire de la Croix-Rousse, Lyon, France.; UMR5510 MATEIS, CNRS, INSA Lyon, Université Lyon 1, Villeurbanne, France., Decullier E; Pôle de Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, France., Huot L; Université Lyon 1, Lyon, France.; Pôle de Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, France., Mathis T; Hospices Civils de Lyon, Service d'Ophtalmologie, Centre Hospitalier Universitaire de la Croix-Rousse, Lyon, France.; Université Lyon 1, Lyon, France.; UMR5510 MATEIS, CNRS, INSA Lyon, Université Lyon 1, Villeurbanne, France. |
| Source: | Acta ophthalmologica [Acta Ophthalmol] 2023 Feb; Vol. 101 (1), pp. e43-e49. Date of Electronic Publication: 2022 Jul 13. |
| Publication Type: | Clinical Trial; Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-3768 (Electronic) Linking ISSN: 1755375X NLM ISO Abbreviation: Acta Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35822428 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of Aflibercept for the treatment of inflammatory choroidal neovascularization: The ALINEA study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kodjikian+L%22">Kodjikian L</searchLink>; Hospices Civils de Lyon, Service d'Ophtalmologie, Centre Hospitalier Universitaire de la Croix-Rousse, Lyon, France.; Université Lyon 1, Lyon, France.; UMR5510 MATEIS, CNRS, INSA Lyon, Université Lyon 1, Villeurbanne, France.<br /><searchLink fieldCode="AU" term="%22Abukhashabah+A%22">Abukhashabah A</searchLink>; Hospices Civils de Lyon, Service d'Ophtalmologie, Centre Hospitalier Universitaire de la Croix-Rousse, Lyon, France.; Ophthalmology Department, King Abdulaziz University, Rabigh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Fardeau+C%22">Fardeau C</searchLink>; Ophthalmology Department, Reference Center for Rare Diseases, La Pitié-Salpêtriètre Hospital, Paris-Sorbonne University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tadayoni+R%22">Tadayoni R</searchLink>; Université de Paris, Service d'Ophtalmologie, AP-HP, Hôpital Lariboisière, Paris, France.; Service d'Ophtalmologie, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.<br /><searchLink fieldCode="AU" term="%22Brézin+A%22">Brézin A</searchLink>; Hôpital Cochin, Service d'Ophtalmologie, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dumas+S%22">Dumas S</searchLink>; Centre Nordretine, Lille, France.<br /><searchLink fieldCode="AU" term="%22Weber+M%22">Weber M</searchLink>; Hôpital Universitaire Centre Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Bernard+L%22">Bernard L</searchLink>; Université Lyon 1, Lyon, France.; Pôle de Santé Publique, Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Lyon, France.; CNRS, UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, Villeurbane, France.<br /><searchLink fieldCode="AU" term="%22Loria+O%22">Loria O</searchLink>; Hospices Civils de Lyon, Service d'Ophtalmologie, Centre Hospitalier Universitaire de la Croix-Rousse, Lyon, France.; UMR5510 MATEIS, CNRS, INSA Lyon, Université Lyon 1, Villeurbanne, France.<br /><searchLink fieldCode="AU" term="%22Decullier+E%22">Decullier E</searchLink>; Pôle de Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Huot+L%22">Huot L</searchLink>; Université Lyon 1, Lyon, France.; Pôle de Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Mathis+T%22">Mathis T</searchLink>; Hospices Civils de Lyon, Service d'Ophtalmologie, Centre Hospitalier Universitaire de la Croix-Rousse, Lyon, France.; Université Lyon 1, Lyon, France.; UMR5510 MATEIS, CNRS, INSA Lyon, Université Lyon 1, Villeurbanne, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101468102%22">Acta ophthalmologica</searchLink> [Acta Ophthalmol] 2023 Feb; Vol. 101 (1), pp. e43-e49. <i>Date of Electronic Publication: </i>2022 Jul 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101468102 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1755-3768 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221755375X%22">1755375X </searchLink><i>NLM ISO Abbreviation: </i>Acta Ophthalmol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35822428 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/aos.15214 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e43 Titles: – TitleFull: Efficacy and safety of Aflibercept for the treatment of inflammatory choroidal neovascularization: The ALINEA study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kodjikian L – PersonEntity: Name: NameFull: Abukhashabah A – PersonEntity: Name: NameFull: Fardeau C – PersonEntity: Name: NameFull: Tadayoni R – PersonEntity: Name: NameFull: Brézin A – PersonEntity: Name: NameFull: Dumas S – PersonEntity: Name: NameFull: Weber M – PersonEntity: Name: NameFull: Bernard L – PersonEntity: Name: NameFull: Loria O – PersonEntity: Name: NameFull: Decullier E – PersonEntity: Name: NameFull: Huot L – PersonEntity: Name: NameFull: Mathis T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2023 Feb Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1755-3768 Numbering: – Type: volume Value: 101 – Type: issue Value: 1 Titles: – TitleFull: Acta ophthalmologica Type: main |
| ResultId | 1 |